Prostate News Archive
14-Sep-2006
Blood Test Spots Prostate Cancer (WebMD)
A novel blood test that spots a protein that is elevated in people with prostate cancer could spare thousands of men from the pain and discomfort of unnecessary biopsies, researchers report. Alternatives to prostate surgery (The Enid News & Eagle)
As you slide out of bed for your fourth trip to the toilet tonight, you may be ready to do almost anything to get a good night?s sleep. For men with similar night-time symptoms, prostate surgery has for many years offered a tempting solution. EntreMed Commences Panzem(R) NCD Phase 2 Study In Prostate Cancer (Medical News Today)
EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developingtherapeutics for the treatment of cancer and inflammatory diseases, todayannounced commencement of a multi-center Phase 2 study with its leadclinical- stage drug candidate, Panzem(R) NCD (2ME2 or 2-methoxyestradiol),in patients with hormone-refractory prostate cancer (HRPC). [click link for full article] Mullin touts prostate cancer checkups (San Mateo County Times)
SOUTH SAN FRANCISCO ? The main character of TV's "Family Guy" made a litigious mountain out of a medical molehill on Sunday's episode when his doctor gave him a prostate exam and wound up in Shift work link tied to prostate cancer (AAP via Yahoo!7 News)
The results of a study suggest there is a significant association between rotating-shift work and prostate cancer. Hollis-Eden Pharmaceuticals Presents Positive Preclinical Data on Compounds Targeting Hormone Refractory Prostate Cancer (Business Wire via Yahoo! Finance)
SAN DIEGO----Sept. 13, 2006--Hollis-Eden Pharmaceuticals, Inc. announced today that its scientists presented data detailing the activity of its steroid compounds in preclinical models of hormone refractory prostate cancer . Rotating-shift work tied to prostate cancer risk (Reuters via Yahoo! News)
The results of a study published in the American Journal of Epidemiology suggest there is a significant association between rotating-shift work and prostate cancer. Sensitive and specific biomarker for early detection of prostate cancer identified (EurekAlert!)
CHICAGO -- Scientists at a Maryland-based pharmaceutical company have preliminary evidence showing that a protein in the blood may prove to be a biomarker that is more sensitive and specific than current methods of early detection for prostate cancer. tNOX serves as a serum marker for detection and monitoring of disease progression in prostate cancer (EurekAlert!)
CHICAGO -- A team of researchers at Purdue University has found a protein in the blood that may prove to be more reliable than the standard prostate specific antigen (PSA) test in measuring the extent of prostate cancer. Do You Know the Signs and Symptoms of Prostate Cancer? (Newswise)
September is prostate Cancer Awareness Month and the American Society for Therapeutic Radiology and Oncology (ASTRO) is encouraging men to get educated when it comes to prostate cancer awareness, screening and their treatment options.
Back to Prostate News Archive
